Clinical trial underway for potential Long COVID treatment A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential t...

Aber es läuft eine Studie zu etwaigem Nutzen von #Kavigale bei #LongCovid:
"Clinical trial underway for potential Long COVID treatment"
www.eurekalert.org/news-release...
4/4

I am so happy for Emma♥️

She has been an amazing advocate for ppl with #longcovid in #Sweden while her own health has just declined...

I hope that this can be a turnaround for her and a breakthrough in general!🙏♥️

#monoclonalantibodies
#kavigale
#longcovid
#pots
#postcovid
#karolinska
#Stockholm